BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8740403)

  • 1. K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas.
    Satoh K; Shimosegawa T; Moriizumi S; Koizumi M; Toyota T
    Pancreas; 1996 May; 12(4):362-8. PubMed ID: 8740403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The point mutation of c-Ki-ras at codon 12 in carcinoma of the pancreatic head region and in intraductal mucin-hypersecreting neoplasm of the pancreas.
    Satoh K; Sawai T; Shimosegawa T; Koizumi M; Yamazaki T; Mochizuki F; Toyota T
    Int J Pancreatol; 1993 Oct; 14(2):135-43. PubMed ID: 8283077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of K-ras codon 12 mutations and p53 overexpression in colorectal nodule-aggregating tumors.
    Kusaka T; Fukui H; Sano Y; Ueda Y; Chiba T; Fujimori T
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1151-7. PubMed ID: 11106095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of p53 and cyclin A in intraductal mucin-hypersecreting neoplasm of the pancreas compared with usual pancreatic ductal adenocarcinoma.
    Mukawa K; Kawa S; Aoki Y; Zhai Y; Nikaido T
    Am J Gastroenterol; 1999 Aug; 94(8):2263-7. PubMed ID: 10445560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological study of intraductal papillary mucinous tumor of the pancreas: special reference to the roles of Survivin and p53 in tumorigenesis of IPMT.
    Jinfeng M; Kimura W; Sakurai F; Moriya T; Takeshita A; Hirai I
    Int J Gastrointest Cancer; 2002; 32(2-3):73-81. PubMed ID: 12794243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunohistochemical study of the c-erbB-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas.
    Satoh K; Sasano H; Shimosegawa T; Koizumi M; Yamazaki T; Mochizuki F; Kobayashi N; Okano T; Toyota T; Sawai T
    Cancer; 1993 Jul; 72(1):51-6. PubMed ID: 8099533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular markers for diagnostic cytology of neoplasms in the head region of the pancreas: mutation of K-ras and overexpression of the p53 protein product.
    van Es JM; Polak MM; van den Berg FM; Ramsoekh TB; Craanen ME; Hruban RH; Offerhaus GJ
    J Clin Pathol; 1995 Mar; 48(3):218-22. PubMed ID: 7730480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of genetic alterations in the p53 suppressor gene and the K-ras oncogene among different grades of dysplasia in patients with colorectal adenomas.
    Hosaka S; Aoki Y; Akamatsu T; Nakamura N; Hosaka N; Kiyosawa K
    Cancer; 2002 Jan; 94(1):219-27. PubMed ID: 11815980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras gene mutations and loss of heterozygosity at the p53 gene locus relative to histological characteristics of mucin-producing tumors of the pancreas.
    Sakai Y; Yanagisawa A; Shimada M; Hidaka E; Seki M; Tada Y; Harada T; Saisho H; Kato Y
    Hum Pathol; 2000 Jul; 31(7):795-803. PubMed ID: 10923915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region.
    Sturm PD; Hruban RH; Ramsoekh TB; Noorduyn LA; Tytgat GN; Gouma DJ; Offerhaus GJ
    J Pathol; 1998 Nov; 186(3):247-53. PubMed ID: 10211112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent K-ras mutations and absence of p53 mutations in mucin-producing tumors of the pancreas.
    Hoshi T; Imai M; Ogawa K
    J Surg Oncol; 1994 Feb; 55(2):84-91. PubMed ID: 8121190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of malignant insulinoma.
    Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
    Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.
    DiGiuseppe JA; Hruban RH; Offerhaus GJ; Clement MJ; van den Berg FM; Cameron JL; van Mansfeld AD
    Am J Pathol; 1994 May; 144(5):889-95. PubMed ID: 8178941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of K-ras and p53 gene mutations in pancreatic juice for the diagnosis of intraductal papillary mucinous tumors.
    Kaino M; Kondoh S; Okita S; Hatano S; Shiraishi K; Kaino S; Okita K
    Pancreas; 1999 Apr; 18(3):294-9. PubMed ID: 10206488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater.
    Matsubayashi H; Watanabe H; Yamaguchi T; Ajioka Y; Nishikura K; Kijima H; Saito T
    Cancer; 1999 Aug; 86(4):596-607. PubMed ID: 10440687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
    Mueller J; Gansauge S; Mattfeldt T
    Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
    Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC
    Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
    Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
    Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy.
    Jimenez RE; Warshaw AL; Z'graggen K; Hartwig W; Taylor DZ; Compton CC; Fernández-del Castillo C
    Ann Surg; 1999 Oct; 230(4):501-9; discussion 509-11. PubMed ID: 10522720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.